Sandostatin LAR depot 20 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26FA0KR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,801
Award facts
- Contract value 100% obligated
- $15,800.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,800.93 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits on December 3, 2025, with a completion date of December 4, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems, supplying an extensive range of brand-name and generic medications, vaccines, and specialized medical supplies.
Sandostatin LAR Depot is a long-acting octreotide injection used for managing acromegaly and neuroendocrine tumors, representing a specialized pharmaceutical product within AmerisourceBergen's comprehensive healthcare commodity portfolio. As a major pharmaceutical distributor consistently awarded federal contracts through open competition, AmerisourceBergen demonstrates the capability to fulfill federal medical supply requirements across multiple therapeutic domains. The company's federal contract awards with DLA range from small-value transactions to substantial orders exceeding $45,000, enabling it to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles supporting military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FA0KR?
SPE2DR26FA0KR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FA0KR worth?
The government has obligated $15,801 on SPE2DR26FA0KR.
Is contract SPE2DR26FA0KR an order under another contract?
Yes. SPE2DR26FA0KR is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0KR competed?
The extent of competition for SPE2DR26FA0KR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award